Author:
Weller Michael,Stupp Roger,Reifenberger Guido,Brandes Alba A.,van den Bent Martin J.,Wick Wolfgang,Hegi Monika E.
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology (clinical)
Reference93 articles.
1. Gerson, S. L. MGMT: its role in cancer aetiology and cancer therapeutics. Nature Rev. Cancer 4, 296–307 (2004).
2. Kaina, B., Christmann, M., Naumann, S. & Roos, W. P. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst.) 6, 1079–1099 (2007).
3. Pegg, A. E. Repair of O6-alkylguanine by alkyltransferases. Mutat. Res. 462, 83–100 (2000).
4. Ochs, K. & Kaina, B. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. Cancer Res. 60, 5815–5824 (2000).
5. Stojic, L. et al. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev. 18, 1331–1344 (2004).
Cited by
636 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献